TY - JOUR
T1 - Solitary bone and extramedullary plasmacytoma.
AU - Weber, Donna M.
PY - 2005
Y1 - 2005
N2 - Less than 5% of patients with a plasma cell dyscrasia present with a single bone (SBP) or extramedullary plasmacytoma (EMP) without evidence of systemic disease (normocalcemia, absence of anemia, preservation of uninvolved immunoglobulins, or renal disease attributable to myeloma). Diagnosis requires biopsy confirmation of a monoclonal plasma cell infiltrate from a single site. The treatment of choice for both entities is radiotherapy given with curative intent (> 4000 cGy) resulting in long term disease-free survival in approximately 30% of patients with SBP and 65% of patients with EMP.
AB - Less than 5% of patients with a plasma cell dyscrasia present with a single bone (SBP) or extramedullary plasmacytoma (EMP) without evidence of systemic disease (normocalcemia, absence of anemia, preservation of uninvolved immunoglobulins, or renal disease attributable to myeloma). Diagnosis requires biopsy confirmation of a monoclonal plasma cell infiltrate from a single site. The treatment of choice for both entities is radiotherapy given with curative intent (> 4000 cGy) resulting in long term disease-free survival in approximately 30% of patients with SBP and 65% of patients with EMP.
UR - http://www.scopus.com/inward/record.url?scp=33845492544&partnerID=8YFLogxK
UR - http://www.scopus.com/inward/citedby.url?scp=33845492544&partnerID=8YFLogxK
U2 - 10.1182/asheducation-2005.1.373
DO - 10.1182/asheducation-2005.1.373
M3 - Article
C2 - 16304406
AN - SCOPUS:33845492544
SN - 1520-4391
SP - 373
EP - 376
JO - Hematology / the Education Program of the American Society of Hematology. American Society of Hematology. Education Program
JF - Hematology / the Education Program of the American Society of Hematology. American Society of Hematology. Education Program
ER -